Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.83B |
| 2 |
Wells Fargo
WFC
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Home Depot
HD
|
+$247M |
| 5 |
Alibaba
BABA
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$414M |
| 2 |
Lowe's Companies
LOW
|
+$326M |
| 3 |
Las Vegas Sands
LVS
|
+$265M |
| 4 |
AABA
Altaba Inc
AABA
|
+$249M |
| 5 |
NBL
Noble Energy, Inc.
NBL
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.45% |
| 2 | Technology | 8.65% |
| 3 | Financials | 8.6% |
| 4 | Consumer Discretionary | 7.75% |
| 5 | Industrials | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PROS
3276
DELISTED
ProSight Global, Inc.
PROS
| $566K | ﹤0.01% |
35,109
-274,434
| -89% | -$4.63M |
|
|
VIE
3277
DELISTED
Viela Bio, Inc. Common Stock
VIE
| $566K | ﹤0.01% |
+20,861
| New | +$526K |
|
3278
Cohen & Steers
CNS
$4.27B
| $565K | ﹤0.01% |
+9,004
| New | +$570K |
|
3279
Community Health Systems
CYH
$419M
| $565K | ﹤0.01% |
194,880
+57,662
| +42% | +$200K |
|
|
SURF
3280
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $562K | ﹤0.01% |
298,831
-191,330
| -39% | -$319K |
|
3281
Barrett Business Services
BBSI
$819M
| $561K | ﹤0.01% |
24,820
-54,980
| -69% | -$1.22M |
|
3282
Metallus
MTUS
$800M
| $561K | ﹤0.01% |
71,317
+12,187
| +21% | +$76.4K |
|
|
JNCE
3283
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $561K | ﹤0.01% |
64,289
-94,294
| -59% | -$510K |
|
3284
First Internet Bancorp
INBK
$249M
| $560K | ﹤0.01% |
+23,620
| New | +$537K |
|
3285
REX American Resources
REX
$1.37B
| $560K | ﹤0.01% |
40,962
+10,728
| +35% | +$148K |
|
3286
AdaptHealth
AHCO
$731M
| $558K | ﹤0.01% |
+50,835
| New | +$505K |
|
|
PRVB
3287
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $556K | ﹤0.01% |
37,313
+15,989
| +75% | +$142K |
|
3288
PUT
Cummins
CMI
$78.8B
| $555K | ﹤0.01% |
3,100
-3,900
| -56% | -$686K |
|
|
KDMN
3289
CALL
DELISTED
Kadmon Holdings, Inc.
KDMN
| $555K | ﹤0.01% |
+122,500
| New | +$448K |
|
3290
Weibo
WB
$1.75B
| $554K | ﹤0.01% |
11,954
-7,892
| -40% | -$369K |
|
3291
Investar Holding Corp
ISTR
$417M
| $553K | ﹤0.01% |
23,030
+10,229
| +80% | +$252K |
|
|
MOR
3292
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $553K | ﹤0.01% |
15,506
-51,860
| -77% | -$1.55M |
|
3293
CALL
Alaska Air
ALK
$4.84B
| $549K | ﹤0.01% |
+8,100
| New | +$553K |
|
|
DUO
3294
Fangdd Network Group
DUO
$25.8M
| $549K | ﹤0.01% |
+10
| New | +$495K |
|
3295
Vanguard Long-Term Bond ETF
BLV
$5.78B
| $546K | ﹤0.01% |
+5,440
| New | +$551K |
|
3296
Mirum Pharmaceuticals
MIRM
$5.98B
| $546K | ﹤0.01% |
22,271
-103,153
| -82% | -$1.1M |
|
3297
Gogo Inc
GOGO
$369M
| $545K | ﹤0.01% |
85,193
-729,469
| -90% | -$4.25M |
|
|
MEET
3298
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $544K | ﹤0.01% |
108,525
-132,344
| -55% | -$622K |
|
|
B
3299
DELISTED
Barnes Group Inc.
B
| $543K | ﹤0.01% |
8,766
-3,776
| -30% | -$218K |
|
3300
Cogent Communications
CCOI
$506M
| $540K | ﹤0.01% |
8,206
-417,961
| -98% | -$25.2M |
|
Similar funds
Israel Englander's Q4 2019 Portfolio in Review
As of Q4 2019, Israel Englander held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Israel Englander deployed $9.74B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.
By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.
- Israel Englander's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
- Israel Englander's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
- Israel Englander fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
- Israel Englander's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
- Israel Englander opened 829 new positions and closed 796 in Q4 2019.
- Israel Englander's portfolio value rose 26% quarter-over-quarter to $79.9B.
Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.